Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of treatment of vaginal intraepithelial neoplasia (VAIN)
2016-000746-59Phase 4Completed
- Sponsor
- Helsinki University Women's Hospital
- Start
- Feb 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of imiquimod in vaginal intraepithelial neoplasia (VAIN) (2 arms), sponsored by Helsinki University Women's Hospital. Started Feb 2016; status: completed.
02
Drugs
imiquimod
03
Conditions
vaginal intraepithelial neoplasia (VAIN)
Beyond the preview
Go deeper on 2016-000746-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000746-59.